William Aliski is Director at Ultragenyx Pharmaceutical Inc. (RARE). They have made 12 open-market trades across 2 companies since 2014, most recently 2024-06-10.
CIK 0001598426
2 open-market purchases totalling $124K since 2014, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RARE | SELL | 2021-02-19 | 2021-02-23 | $149.01 | $1.1M | -15.4% | -20.8% | -24.6% |
| RARE | SELL | 2020-08-21 | 2020-08-25 | $86.57 | $866K | -12.9% | -8.0% | +31.8% |
| RARE | SELL | 2020-05-18 | 2020-06-03 | $74.02 | $1.5M | -3.7% | +20.7% | +14.5% |
| RARE | SELL | 2020-05-18 | 2020-05-20 | $74.65 | $560K | +6.3% | +10.7% | +24.5% |
| AGTC | BUY | 2018-12-14 | 2018-12-18 | $3.25 | $19K | -13.8% | +3.8% | +47.1% |
| RARE | SELL | 2018-12-07 | 2018-12-07 | $49.69 | $298K | -7.0% | -3.9% | +35.8% |
| RARE | SELL | 2018-11-08 | 2018-11-08 | $55.67 | $334K | -5.8% | -12.0% | -3.0% |
| RARE | SELL | 2018-08-08 | 2018-08-08 | $76.66 | $287K | -0.2% | +9.4% | -29.9% |
| RARE | SELL | 2016-12-05 | 2016-12-05 | $78.19 | $469K | -6.1% | -2.1% | +13.8% |
| RARE | SELL | 2015-05-12 | 2018-10-09 | $71.15 | $2.1M | -10.6% | -22.7% | -37.0% |
| RARE | SELL | 2014-12-04 | 2014-12-08 | $42.16 | $253K | -29.4% | -6.4% | -6.4% |
| RARE | BUY | 2014-01-30 | 2014-02-03 | $21.00 | $105K | -29.4% | -6.4% | -6.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.